The growth in cannabis sales appears to have brought some relief to cannabis stocks, which have been going through a rough period. High-flying and volatile cannabis stocks have caught the attention of both the Main street and Wall Street this year. For investors ready to jump on the hemp CBD bandwagon.
Stocks are massively oversold. A bounce is coming. Fear has gripped the markets to such an extent that anyone left with a sober mind sees opportunity across the board. Bears are going to hibernate for a couple of weeks. That means it’s time to slowly start buying stocks that have lost over 50% of their value in the rout. Whatever happens, the economy will bounce back, and the stock market with it. A good time to buy low.
TransAtlantic Capital Inc.(OTC: TACI) An emerging diversified investment vehicle focused on three key industries. -Housing The Caribbean/African market place has the fastest growing middle class worldwide. -Maritime Shipping 90 Percent of all global trade happens via Water. -Agriculture encompassing. Cannabis, Hemp, Psilocybin grow processing and research in legal global Markets.
The company recently signed land deal for 250 acres to grow cannabis and psilocybin
mushrooms in Jamaica.
This 250 acre parcel will allow the Company to create and build the largest cannabis and magic mushroom” operation in the carribean . This facility could produce upwards of 100k pounds annually for export to licensed countries throughout the world.
“We are truly now, beginning to dig in,” stated Julius Jenge, Chief Executive Officer of TACI , Inc. Our commitment to research, production and distribution of psilocybin mushrooms, and cannabis is now a reality, effective today after acquiring the Clarendon Jamaica property. We now have a very solid plan in place, and we anticipate great things coming to fruition.”
CV Sciences, Inc. (OTC: CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a pharmaceutical division focused on developing and commercializing CBD-based novel therapeutics.
The Company’s PlusCBD Oil consumer products are sold at more than 5,500 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD in the natural product retail market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry.
CV Sciences’ state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP) and the Company’s hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm purity and content to meet strict company quality standards. With a commitment to science, PlusCBD Oil’s benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. PlusCBD Oil was the first hemp-derived CBD supplement brand to invest in the scientific evidence necessary to achieve self-affirmed Generally Recognized as Safe (GRAS) status.
The Company’s pharmaceutical division focuses on developing and commercializing proprietary prescription drugs utilizing cannabidiol (CBD) as the active pharmaceutical ingredient. CV Sciences initial drug candidate (CVSI-007) combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at greater than $2 billion.
Sciences initial drug candidate (CVSI-007) combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at greater than $2 billion.
Canopy Growth Corporation (NYSE: CGC), together with its subsidiaries, engages in engages in production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company’s products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector.
Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of a mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Aurora Cannabis Inc. (NYSE: ACB) produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
The company produces various strains of dried cannabis, cannabis oil and capsules, and topicals kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services.
The company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.